Abstract:Highlights • A detailed architecture of nuclear pore complex (NPC) provides the basis for understanding the mechanism of diseases like cancers at NPC. • Variations in different building block nucleoporins of NPC, result in altered cellular pathways associated with colorectal cancer. • Dysregulation of nucleocytoplasmic transport via NPC by defected karyopherins, contributes to a number of disorders including colorectal cancer. • Inhibitors of karyopherins at present have potential to regulate the altered level/expression of these karyopherin molecules. • Development of novel and more effective karyopherin inhibitors may provide more effective therapeutic strategies for colorectal cancer. Background Nuclear pore complexes (NPCs) are the architectures entrenched in nuclear envelop of a cell that regulate the nucleo-cytoplasmic transportation of materials such as proteins and RNAs for proper functioning of a cell. The appropriate localization of proteins and RNAs within the cell is essential for its normal functionality. For such a complex transportation of materials across the NPC, around 60 proteins are involved comprising nucleoporins, karyopherins and RAN system proteins that play a vital role in NPC's structure formation, cargo translocation across NPC, and cargoes' rapid directed transportation respectively. In various cancers, the structure and function of NPC is often exaggerated, following altered expressions of its nucleoporins and karyopherins, affecting other proteins of associated signaling pathways. Some inhibitors of karyopherins at present have potential to regulate the altered level/expression of these karyopherin molecules. Aim of Review This review summarizes the data from 1990 to 2023, mainly focusing on recent studies that illustrate the structure and function of NPC, the relationship and mechanisms of nucleoporins and karyopherins with colorectal cancer, as well as therapeutic values, in order to understand the pathology and underlying basis of colorectal cancer associated with NPC. This is the first review to our knowledge elucidating the detailed updated studies targeting colorectal cancer at NPC. The review also aims to target certain karyopherins, nups and their possible inhibitors and activators molecules as a therapeutic strategy. Key Scientific Concepts of Review NPC structure provides understanding, how nucleoporins and karyopherins as key molecules are responsible for appropriate nucleocytoplasmic transportation. Many studies provide evidences describing the role of disrupted nucleoporins and karyopherins not only in CRC but also in other non-hematological and hematological malignancies. At present, some inhibitors of karyopherins have therapeutic potential for CRC, however development of more potent inhibitors may provide more effective therapeutic strategies for CRC in near future. Graphical abstract Download : Download high-res image (182KB) Download : Download full-size image

Targeting colorectal cancer at the level of nuclear pore complex

The Potential of Nuclear Pore Complexes in Cancer Therapy

Nup210 Promotes Colorectal Cancer Progression by Regulating Nuclear Plasma Transport

Advances in the understanding of nuclear pore complexes in human diseases

Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment

Nuclear‐targeting Peptides for Cancer Therapy

A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis

The Interaction Between S100A2 and KPNA2 Mediates NFYA Nuclear Import and is a Novel Therapeutic Target for Colorectal Cancer Metastasis.

Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy

Abstract 3006: Morphogen-driven regulation of nuclear shape and its implication for colorectal cancer

The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles

Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma

Up-regulation of Polo-like Kinase 1 in Nasopharyngeal Carcinoma Tissues: a Comprehensive Investigation Based on RNA-sequencing, Gene Chips, and In-House Tissue Arrays.

Nuclear pore dysfunction and disease: a complex opportunity

Therapeutic Approaches Targeting Nucleolus in Cancer

Targeting Nuclear Pore Complex to Radiosensitize Glioblastoma Stem Cells

An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

The cellular environment shapes the nuclear pore complex architecture

KIF3A Inhibits NPC Proliferation, Migration and Invasion By Interacting With β-Catenin To Suppress Its Nuclear Accumulation

Non-classical functions of nuclear pore proteins in ciliopathy